Physician Wealth Advisors’s Haemonetics HAE Stock Holding History

Physician Wealth Advisors’s Portfolio HAE Stock Details HAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$975	Buy	+13	New	+$835	﹤0.01%	1850

Other funds holding HAE

River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

Isthmus Partners Madison, Wisconsin $1.03B AUM 22.86% 1-Year Est. Return

Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return

Assenagon Asset Management

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

QV Investors Calgary, Alberta, Canada $1.3B AUM 31.14% 1-Year Est. Return

Cary Street Partners Richmond, Virginia $4.58B AUM 24% 1-Year Est. Return

Cardinal Capital Management Inc (North Carolina) Raleigh, North Carolina $826M AUM 32.06% 1-Year Est. Return

Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return

Hunter Perkins Capital Management Lombard, Illinois $446M AUM 25.88% 1-Year Est. Return

Physician Wealth Advisors's HAE Position: Q2 2026 in Review

Physician Wealth Advisors opened a new position in Haemonetics (HAE) in Q2 2026: 13 shares worth $975. The stake represents ﹤0.01% of the portfolio and ranks #1850 among its holdings.

42 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

Physician Wealth Advisors held 13 shares of Haemonetics worth $975 as of Q2 2026.
Haemonetics was a new Physician Wealth Advisors position in Q2 2026.
Haemonetics made up ﹤0.01% of Physician Wealth Advisors's portfolio in Q2 2026, its #1850 holding.
42 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on Physician Wealth Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.